by rss feed | Sep 21, 2023 | BioBurst, Burst Biologics, Investigative, News Feeds, perinatal stem cells
The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers. The story also bears on the doctors and hospitals like Weill Cornell that were or are customers of the...
